In this exclusive Healio Video Perspective from the American Academy of Ophthalmology meeting, Steve R. Sarkisian Jr., MD, ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular ...

Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing loss are all ...

ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...

Eye doctors are in a big fight at the New Hampshire State House over who can perform certain laser procedures to treat ...

AIIMS Jodhpur study shows trabeculectomy improves quality of life and lowers eye pressure in moderate–severe glaucoma, ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.

East Bay Surgery Center (EBSC) in Swansea, Massachusetts, has been recognized by The Leapfrog Group as a "Top Ambulatory ...

During his regular eye test at Specsavers in Bridgnorth, optician and store director, Teresa Hughes, noticed an issue with ...

We are honored to feature Dr. Andrew Osborn in our Missouri Eye Institute spotlight. Missouri Eye Institute’s conveniently ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...